TBP.TO实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (7 Mar 2023 @ 04:59):

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology...

Stats
今日成交量	476 110
平均成交量	0.00
市值	10.58M
EPS	$0 ( 2023-11-03 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.313
ATR14	$0 (0.00%)

音量相关性

長: 0.06 (neutral)

短: 0.00 (neutral)

Signal:(52.174) Neutral

TETRA BIO PHARMA INC 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

TETRA BIO PHARMA INC 相关性 - 货币/商品

0.00
( neutral )

0.64
( weak )

-0.14
( neutral )

TETRA BIO PHARMA INC 财务报表

Annual	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.202

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.202

FY	2020
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.100

FY	2019
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.0800

Financial Reports:

No articles found.

TETRA BIO PHARMA INC

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. The company is headquartered in Orléans, Canada.